The endoplasmic reticulum (ER) stress response (ERSR) is activated to maintain protein homeostasis or induce apoptosis in the ER in response to distinct cellular insults including hypoxia, inflammation, and oxidative damage. Recently, we showed ERSR activation in a mouse model of a contusive spinal cord injury (SCI) and an improved hindlimb locomotor function following SCI when the pro-apoptotic arm of ERSR was genetically inhibited. The objective of the current study was to explore if the pharmacological enhancement of the homeostatic arm of the ERSR pathway can improve the functional outcome after SCI. Salubrinal enhances the homeostatic arm of the ERSR by increasing phosphorylation of eIF2α. Salubrinal significantly enhanced the levels of phosphorylated eIF2α protein and modulated the downstream ERSR effectors assessed at the lesion epicenter 6 h post-SCI. Hindlimb locomotion showed significant improvement in animals treated with salubrinal. Treadmill-based-gait assessment showed a significant increase in maximum speed of coordinated walking and a decrease in rear stance time and stride length in salubrinal-treated animals. This improved functional recovery corresponded with increased white matter sparing and decreased oligodendrocyte apoptosis. In addition, salubrinal protected cultured mouse oligodendrocyte progenitor cells against the ER stress-inducing toxin tunicamycin. These data suggest that boosting the homeostatic arm of the ERSR reduces oligodendrocyte loss after traumatic SCI and support the contention that pharmacological targeting of the ERSR after CNS trauma is a therapeutically viable approach.
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Introduction
Despite numerous research endeavors and technological advances, effective clinical therapy after spinal cord injury (SCI) still remains obscure. This unavailability of treatment is due to the complex pathophysiology that ensues after SCI which includes inflammation, hypoxia, excitotoxicity, disruption of the blood brain barrier, ischemia and demyelination (Rowland et al., 2008) . Therefore, studies are required to explore additional molecular mechanisms for identification of cellular targets for therapeutic intervention. Recent reports demonstrated activation of the endoplasmic reticulum (ER) stress response (ERSR) after a moderate contusive SCI in rats (Penas et al., 2007 ) and mice (Ohri et al., 2011) and improved functional recovery in hindlimb locomotion of mice deficient in the ERSR pro-apoptotic effector, C/EBP (CCAAT enhancer binding protein) homologous protein (CHOP) (Ohri et al., 2011) .
The ERSR, mediated through three distinct pathways, is an evolutionary conserved cellular mechanism that is activated in response to insults that disrupt cellular homeostasis (Schroder, 2008; Tabas and Ron, 2011) . The protein RNA (PKR)-like kinase (PERK) phosphorylates the α-subunit of elongation initiation factor 2α (eIF2α) and inhibits global protein synthesis. Activated inositol-requiring protein-1α (IRE-1α) splices X-box-binding protein 1 (XBP1) mRNA (Yoshida et al., 2001) which then activates ERSR specific transcription. The third pathway of the ERSR comprises the proteolytic processing of activating transcription factor-6 (ATF6) (Haze et al., 1999) . The main objective of the ERSR is restoration of ER function and, in consequence, cytoprotection. However, the ERSR may also activate apoptosis if ER function cannot be timely restored (Tabas and Ron, 2011) . CHOP is one of the major effectors of the apoptotic arm of the ERSR (Ron and Habener, 1992) . Involvement of ERSR-activated cell death has been reported in ischemic stroke (Lange et al., 2008) , multiple sclerosis (Lin et al., 2006) , and Alzheimer's disease (Milhavet et al., 2002 
